Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
Portfolio Pulse from Adam Eckert
Several healthcare stocks related to mpox are experiencing significant movements after the WHO declared a public health emergency due to an mpox outbreak in Africa. Emergent Biosolutions, Bavarian Nordic, GeoVax Labs, and SIGA Technologies are among the companies affected.
August 15, 2024 | 5:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bavarian Nordic shares fell 9.77% despite WHO's emergency declaration. BVNRY's JYNNEOS is another CDC-recommended vaccine for mpox.
Despite the WHO's declaration, BVNRY shares fell, possibly due to market dynamics or other underlying factors not detailed in the article.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
SIGA Technologies shares dropped 29.4% after a trial for its antiviral drug TPOXX did not meet its primary endpoint, despite initial gains from the WHO's emergency declaration.
The failure of the TPOXX trial to meet its primary endpoint has significantly impacted SIGA's stock, outweighing the positive news from the WHO.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Emergent Biosolutions shares surged 12.3% after WHO declared a public health emergency for mpox. EBS owns ACAM2000, one of the CDC-recommended vaccines for mpox.
The WHO's declaration of a public health emergency has increased demand for mpox vaccines, benefiting EBS, which owns one of the recommended vaccines.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
GeoVax shares rose 13.5% as the company has published data suggesting its vaccines help prevent mpox. The stock is up 83% over the past week.
Positive data on GeoVax's vaccines and the WHO's emergency declaration have driven up GOVX shares significantly.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75